# Fibrex Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fibrex-medical

- Industry: Biotechnology
- Headquarters: Vienna, Austria
- Website: www.fibrexmedical.com
- Total disclosed funding: $10M
- Latest round: Series A (Mar 14, 2005)
- Investors on record: 4

## About

Fibrex Medical Inc. focuses on developing advanced medical technologies to enhance patient care and operational efficiency in healthcare environments.Founded in 2001 and headquartered in Vienna, Austria, Fibrex Medical Inc. specializes in creating innovative medical devices and diagnostic tools. The company has undergone strategic pivots to better address the needs of healthcare facilities. Fibrex Medical has raised a total of USD 10.00 mn through funding rounds, with the latest being a Series A round in August 2014, which included investments from Atlas Venture, EMBL Ventures, Global Life Science Ventures, and Mulligan Biocapital.Fibrex Medical specializes in developing advanced medical technologies and solutions aimed at enhancing patient care and operational efficiency in healthcare settings. The company's core product offerings include innovative medical devices and diagnostic tools designed to improve patient monitoring and treatment outcomes. These products address critical needs within healthcare facilities by providing real-time data and analytics, allowing healthcare professionals to make informed decisions rapidly. Fibrex Medical serves a diverse clientele, including hospitals, outpatient clinics, and specialty care centers, with a strong emphasis on the North American and European markets. The company's products are tailored to various end users, including clinicians, nurses, and healthcare administrators, who rely on these technologies to optimize patient care and streamline workflows.Fibrex Medical generates revenue through a combination of direct sales and strategic partnerships within the healthcare sector. The company structures its transactions primarily through B2B relationships, offering its products to healthcare providers and facilities that require advanced medical technologies. Revenue streams include one-time purchases, ongoing service agreements, and subscription models for software solutions associated with their medical devices. Specific pricing plans are tailored to align with the needs of clients, ensuring competitive rates for flagship products that enhance patient monitoring and diagnostics. By focusing on building long-term relationships with healthcare organizations, Fibrex Medical positions itself as a key provider in the medical technology landscape, driving consistent revenue growth through its innovative offerings.Fibrex Medical plans to launch new products aimed at improving healthcare delivery, with specific release dates to be announced. The company is targeting expansion into additional European markets by 2025, leveraging recent funding from the Series A round to support these initiatives. The funding will be utilized to enhance product development and market entry strategies, further establishing Fibrex Medical within the global healthcare technology industry.

## Funding rounds

- Series A, Mar 14, 2005, $10M — Atlas Venture, Global Life Science Ventures, EMBL Ventures, Mulligan Biocapital

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A
- Global Life Science Ventures (https://capitalatlas.ai/funds/global-life-science-ventures) — Series A
- EMBL Ventures (https://capitalatlas.ai/funds/embl-ventures) — Series A
- Mulligan Biocapital (https://capitalatlas.ai/funds/mulligan-biocapital) — Series A